Skip to main content
Premium Trial:

Request an Annual Quote

Roche Grants PCR License to Idaho Technology

NEW YORK, Jan. 5 (GenomeWeb News) - Idaho Technology today has licensed non-exclusive worldwide access to Roche's PCR patents.

 

The Salt Lake City-based firm said the agreement provides it with rights to use the technology in in vitro diagnostic products. Terms of the license were not disclosed.

 

Idaho Technology makes instruments for pathogen detection, reagents, and thermocyclers, including the LightCycler, which Roche markets under an agreement signed between the firms in 1997.

 

The privately held firm also announced that it is registered with the US Food and Drug Administration to develop, manufacture, and sell analyte specific reagents for molecular diagnostic purposes.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.